J. Yang et al., Systemic administration of naked plasmid encoding hepatocyte growth factorameliorates chronic renal fibrosis in mice, GENE THER, 8(19), 2001, pp. 1470-1479
The progression of chronic renal diseases Is considered as an irreversible
process that eventually leads to end-stage renal failure characterized by e
xtensive tissue fibrosis. At present, chronic renal fibrosis is incurable a
nd the incidence of affected patients is on the rise worldwide. In this stu
dy, we demonstrate that delivery of hepatocyte growth factor (HGF) gene via
systemic administration of naked plasmid vector markedly ameliorated renal
fibrosis in an animal model of chronic renal disease induced by unilateral
ureteral obstruction. A high level of exogenous HGF protein was detected i
n the obstructed kidneys following intravenous injection of naked plasmid e
ncoding human HGF Delivery of human HGF gene induced a sustained activation
of extracellular signal-regulated kinases-1 and -2 in the obstructed kidne
ys. Exogenous HGF expression dramatically inhibited a-smooth muscle actin e
xpression, attenuated renal interstitial accumulation and deposition of col
lagen I and fibronectin. In addition, exogenous HGF suppressed renal expres
sion of pro-fibrogenic cytokine TGF-beta1 and its type I receptor in vivo.
These results suggest that systemic administration of naked plasmid vector
introduces a high level of exogenous HGF to the diseased kidneys, and that
HGF gene transfer may provide a novel therapeutic strategy for amelioration
of chronic renal fibrosis in vivo.